symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
CMXC,0.03,34.29554,5373,1887693,0,0.0011-0.9312,0.0099,Cell MedX Corp.,USD,0001493712,US15115X1072,15115X107,Other OTC,OTC,Medical Devices,https://www.cellmedx.com,"Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.",Mr. Dwayne  Yaretz,Healthcare,US,,844 238 2692,123 West Nye Ln,Carson City,NV,89706,,0,https://financialmodelingprep.com/image-stock/CMXC.jpg,2013-08-29,False,False,True,False,False
